Well-controlled viremia predicts the outcome of hepatocellular carcinoma in chronic viral hepatitis patients treated with sorafenib

HIGHLIGHTS

  • who: Yuan-Hung Kuo and collaborators from the Division of Hepatogastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan have published the article: Well-Controlled Viremia Predicts the Outcome of Hepatocellular Carcinoma in Chronic Viral Hepatitis Patients Treated with Sorafenib, in the Journal: Cancers 2022, 14, x FOR PEER REVIEW of 15 trolled viremia. (B). Overall survival rates of patients with well-controlled viremia and10uncontrolled of 15/08/2022
  • what: The authors aimed to elucidate the efficacy of concurrent sorafenib and anti-viral treatment for HCC . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?